Results 11 to 20 of about 1,940,460 (362)
Expert Review of Hematology, 2021 Introduction Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by a low platelet count (
J. Bussel +4 more
semanticscholar +5 more sources
Hyperthyroidism and immune thrombocytopenia [PDF]
Postgraduate Medical Journal, 1984 SummaryHyperthyroidism and immune thrombocytopenia occurred concurrently in five patients; in a sixth, thyrotoxicosis developed after successful treatment of the thrombocytopenia. Correction of the hyperthyroidism was followed by a variable pattern of clinical response.
Peter G. Jacobs +2 more
openalex +4 more sources
Haematologica, 2010 Background The risk of thromboembolic events in adults with primary immune thrombocytopenia has been little investigated despite findings of increased susceptibility in other thrombocytopenic autoimmune conditions.
Ameet Sarpatwari +7 more
doaj +3 more sources
Sulfasalazine-induced immune thrombocytopenia [PDF]
Postgraduate Medical Journal, 2007 Abstract Sulfasalazine is a well established disease-modifying anti-rheumatic drug commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. Sulfasalazine was generally well tolerated in clinical trials, the most frequently reported adverse effects being adverse gastrointestinal effects, headache, dizziness ...
Luca Cantarini +4 more
openalex +6 more sources
Success of Helicobacter pylori Eradication Therapy and Long Lasting Platelet Recovery in an Iranian Patient with Severe Immune Thrombocytopenia [PDF]
Journal of Kerman University of Medical Sciences, 2021 Background: Helicobacter pylori is a gram-negative spirochete that usually affects the gastric mucosa and has a prevalence of more than 50% of people worldwide.
Esmaeil Shahabi Satlsar +5 more
doaj +1 more source
COVID-19-associated immune thrombocytopenia [PDF]
Romanian Journal of Infectious Diseases, 2021 The coronavirus disease 2019 (COVID-19) is a contagious respiratory tract infection caused by the betacoronavirus SARS-CoV-2. The World Health Organization declared the COVID-19 outbreak a pandemic on March 11, 2020.
Mara-Andrada Plesu +4 more
doaj +1 more source
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
New England Journal of Medicine, 2021 Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a new syndrome associated with the ChAdOx1 nCoV-19 adenoviral vector vaccine against severe acute respiratory syndrome coronavirus 2. Data are lacking on the clinical features of
S. Pavord +8 more
semanticscholar +1 more source
Hematology, 2013 Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ITP presents as a primary or a secondary form. ITP may affect individuals of all ages, with peaks during childhood and in the elderly, in whom the age-specific incidence of ITP is greatest. Bleeding is the most common clinical manifestation of ITP.
Gaurav, Kistangari, Keith R, McCrae
openaire +4 more sources
Understanding Immune Thrombocytopenia: Looking Out of the Box
Frontiers in Medicine, 2021 The pathogenesis of immune thrombocytopenia (ITP) is increasingly being elucidated, and its etiology is becoming more frequently identified, leading to a diagnostic shift from primary to secondary ITP.
Alexandra Schifferli +8 more
doaj +1 more source
How we treat primary immune thrombocytopenia in adults
Journal of Hematology & Oncology, 2023 Primary immune thrombocytopenia (ITP) is an immune-mediated bleeding disorder characterized by decreased platelet counts and an increased risk of bleeding.
Xinguang Liu, Yu Hou, M. Hou
semanticscholar +1 more source